NOW OPEN AT BERKELEY FAMILY PRACTICE
Clinical Trials of South Carolina is proud to bring medical research to the patients of Berkeley Family Practice. Our organization works with major pharmaceutical industry partners to help study and safely test new medications, devices, treatment and prevention methods. All research trials are designed to assess both the safety and effectiveness of a product and are carefully conducted under rigorous U.S. Food and Drug Administration (FDA) guidelines. Only through patient participation are we able to work to bring important and exciting treatment options to the public.
For individuals with unmet healthcare needs, insurance limitations or those simply looking to help advance medicine, Clinical Trials are a great opportunity for YOU. Through your participation in a research study, you can learn more about your medical condition and receive access to new treatments and medications at no cost to you!
For individuals with unmet healthcare needs, insurance limitations or those simply looking to help advance medicine, Clinical Trials are a great opportunity for YOU. Through your participation in a research study, you can learn more about your medical condition and receive access to new treatments and medications at no cost to you!
CURRENT OPEN TRIALS
ENROLLING NOW
- knee pain
- Arthritis
- Sciatica
- Degenerative Disc Disease
- Migraines
- Hot flashes
- Urinary Tract Infections (UTI)
- Infant Formula
- Vaccines
- Multiple Sclerosis
- GERD
- Diabetic Gastroparesis
- Crohn’s Disease a
- AND MORE!
Are you interested in learning more about participating in clinical trials available at Berkeley Family Practice?
- Fill out a Confidential Enrollment Form (http://www.clinicaltrialssc.com/resources/enroll-in-a-trial/)
- Frequently Asked Questions regarding clinical research (http://esqtxsa.sgoit.com/research-faqs.html)
- The Clinical Trials of South Carolina Team (http://www.clinicaltrialssc.com/staff/)
- Contact Us at one of our multiple locations! (http://www.clinicaltrialssc.com/contact-us-2/)